Article Information
History
- March 9, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Deborah Utjés1,4,¶,
- Nageswara Rao Boggavarapu1,¶,
- Mohammed Rasul1,2,
- Isabelle Koberg1,
- Alexander Zulliger1,
- Sakthivignesh Ponandai-Srinivasan1,
- Carolina von Grothusen1,
- Parameswaran Grace Lalitkumar1,
- Kiriaki Papaikonomou1,4,
- Twana Alkasalias1,3,*,# and
- Kristina Gemzell-Danielsson1,4,5,*
- 1Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
- 2Department of Pharmaceutical Basic Science, Faculty of Pharmacy, Tishk International University, Erbil, Kurdistan Region, Iraq
- 3General Directorate of Scientific Research Center, Salahaddin University-Erbil, Erbil, Kurdi-stan Region, Iraq
- 4Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden
- 5WHO Collaborating Centre, Division of Gynecology and Reproduction, Karolinska University Hospital, Stockholm, Sweden
- ↵#Corresponding Author:
Twana Alkasalias, Assistant professor, Ph.D. in cell and tumor biology, Deparment of Women’s and Children’s, Health, Karolinska Institutet, Biomedicum 4A, Solnavägen 9, 17165, Solna, Stockholm, Sweden Phone: +46 7 39 5581 29, Email: twana.alkasalias{at}ki.se
Posted March 09, 2024.
Transcriptomic profile of normal breast tissue post-mifepristone treatment: secondary outcomes of a randomized controlled trial
